Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Inspector General: NIH must improve conflict of interest reviews
Key clinical point: NIH has improved its financial conflict of interest reviews, but it needs to do more.
Major finding: There are many inconsistencies between centers in the conduct of FCOI reviews.
Study details: OIG collected the number and type of FCOIs that institutions reported in FY2018 from the NIH, conducted interviews with NIH staff, reviewed guidance and training documents and interviewed staff at three NIH centers regarding their procedures for FCOI reviews.
Disclosures: OIG in its oversight capacity makes no disclosures.
Citation:
Murrin S. Office of Inspector General. 2019 Sep 25. OEI-03-19-00150.